Form 13-F position report

NURIX THERAPEUTICS INC

Reported by Foresite Capital Management V LLC

NRIX CUSIP 67080M103 Manager CIK 0001792206

Reported 458,742 shares, up 193,742 (73.1%) from the prior quarter.

Reported value 69.2%; share count 73.1% vs. the prior quarter.

Added
% of reported 13F value 3.76% This manager · Q3 2026
Shares 458,742 Quarter-end amount reported
Reported value $10,876,773 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2026-03-31 4107500
2026-06-30 6428900
2026-09-30 10876773

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for NURIX THERAPEUTICS INC held by Foresite Capital Management V LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 458,742 +193,742 (73.1%) 3.76% $10,876,773 2026-11-16
Q2 2026 Unchanged 265,000 0 (0.0%) 1.77% $6,428,900 2026-08-14
Q1 2026 New 265,000 +265,000 (0.0%) 1.52% $4,107,500 2026-05-15
Q4 2021 Reduced 0 -451,522 (-100.0%) 0 $0 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

255 managers reported NURIX THERAPEUTICS INC for Q3 2026.

Managers reporting NURIX THERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 8,801,242 +30,893 < 0.01% $208,677,448 9 qtrs
Redmile Group LLC Added 7,901,085 +3,827,298 13.71% $187,334,725 25 qtrs
Vestal Point Capital LP Reduced 7,025,000 -1,025,000 4.3% $166,562,750 10 qtrs
Deep Track Capital LP Reduced 6,000,000 -1,736,455 2.32% $142,260,000 18 qtrs
PERCEPTIVE ADVISORS LLC Added 5,371,629 +1,051,207 2.22% $127,361,324 8 qtrs
MORGAN STANLEY Added 5,246,511 +484,027 < 0.01% $124,394,806 25 qtrs
Rubric Capital Management LP Reduced 4,966,827 -2,260,951 1.11% $117,763,468 4 qtrs
FMR LLC Reduced 4,679,815 -805,400 < 0.01% $110,958,424 25 qtrs
BAKER BROS ADVISORS LP Unchanged 4,658,556 0 0.52% $110,454,363 25 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 4,570,774 -865,813 0.01% $108,374,000 25 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
458,742
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.